CALPN - Overview: Calponin Immunostain, Technical Component Only
Marker for myoepithelium when differentiating ductal carcinomas in situ from infiltrating breast carcinoma Characterization of tumors of smooth muscle or myoepithelial lineage
HNF1B - Overview: Hepatocyte Nuclear Factor 1Beta Immunostain, Technical Component Only
Diagnosis of ovarian clear cell carcinoma and endometrial clear cell carcinoma
HALO - Overview: Haloperidol, Serum
Optimizing haloperidol dosage Monitoring patient compliance Assessing toxicity
GATA3 - Overview: GATA Binding Protein 3 Immunostain, Technical Component Only
Characterizing carcinomas, including primary bladder and breast carcinomas, and some types of mesenchymal and neuroectodermal tumors
GALN3 - Overview: Galectin-3 Immunostain, Technical Component Only
Distinguishing normal and benign thyroid gland from thyroid carcinoma
EXT2 - Overview: Exostosin 2 (EXT2) Immunostain, Technical Component Only
Identification of exostosin 2 associated membranous nephropathy
IGAI - Overview: IgA Immunostain, Technical Component Only
Aiding in the classification of lymphomas and multiple myeloma
KIMEL - Overview: Ki67 + Melan A Immunostain, Technical Component Only
Ki67 is a marker of proliferation in neoplasms Melan A aids in the identification of melanoma
KRTAE - Overview: Keratin (AE1/AE3) Immunostain, Technical Component Only
Identification of cells expressing a broad spectrum of cytokeratins (low and high molecular weight keratins)
KRT5 - Overview: Keratin 5 (KRT5) Immunostain, Technical Component Only
Differentiation of mesothelioma and squamous cell carcinoma versus adenocarcinoma
Mayo Clinic Ranked No. 1 Hospital Nationwide by U.S. News & World Report - Insights
Report’s 29th annual "Best Hospitals Honor Roll" published online on August 14. Mayo Clinic also ranked No. 1 in more specialties than any other hospital in the country....
NELL-1 [Test in Focus] - Insights
D., discusses how Mayo Clinic Laboratories’ new immunohistochemistry test for the detection of NELL-1 antigen, a biomarker for membranous nephropathy found in 10% to 15% of patients, provides diagnostic...
Looking Back on Clinical Chemistry 1 - Insights
in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course....
Orexin-A/Hypocretin-1 for the Diagnosis of Type 1 Narcolepsy [Test in Focus] - Insights
test to perform as well as to interpret. The orexin-A/hypocretin-1 test is a sensitive and specific alternative to the MSLT to diagnose type 1 narcolepsy....
Week in Review: November 1 - Insights
Top highlights include: Facebook launches into the digital space of healthcare, medical breakthrough for Ebola, and how the brain makes memories.